Vaccine development for cryptosporidiosis: Systematic review
Keywords:Cryptosporidium spp.; Coccicidiosis; Immunizatio; Zoonosis.
Cryptosporidium spp. are opportunistic parasites with zoonotic potential transmitted by ingestion of contaminated water and food, the infection consists of severe diarrhea leading to the death of babies and immunocompromised individuals. In the veterinary, it can generate economic losses due to the death of calves, these animals being a possible source of transmission of the parasite. Nitazoxanide and halofuginone are the only drugs approved for treatment in humans and calves respectively, however there are restrictions on their use. There is still no vaccine against cryptosporidiosis in humans or animals and its development is a great challenge. Our objective with the present work was to write a systematic review of the literature addressing the progress of studies on vaccines against cryptosporidiosis. The recommended guidelines for RSL were used, with the aid of the StArt software (State of the Art through Systematic Rewiews). The research took place in the databases: Lilacs, PubMed, Scielo, Science Direct, Scopus, Embase and Medline. In 30% of the selected articles, the calves were the study animal and in 50% the mice; 40% of the studies were with vaccines derived from recombinant proteins and 30% of the research was aimed at inhibiting the parasite from entering cells and activating the host's protective immunity. So far, a vaccine with no proven efficacy or an ideal cost-benefit has been developed. Many candidate antigenic targets for a vaccine have been characterized, in addition to elucidating the immunogenicity mechanism of Cryptosporidium spp. in the infected individual. However, another antigenic targets for a vaccine can be searched in future studies.
Askari, N., Shayan, P., Mokhber-dezfouli, M. R., Ebrahimzadeh, E., Lotfollahzadeh, S., Rostami, A., Amininia, N., & Ragh, M. J. (2016). Evaluation of recombinant P23 protein as a vaccine for passive immunization of newborn calves against Cryptosporidium parvum. Parasite Immunology, 38, 282–289. doi: 10.1111/pim.12317
Avendaño, C., Jenkins, M., Méndez-callejas, G., Oviedo, J., Guzmán, F., Patarroyo, M. A., Sánchez-acedo, C., & Quílez, J., (2018). Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides’ immunogenicity and in vitro seroneutralisation capability. Vaccine, 36, 45, 6703–6710. doi: 10.1016/j.vaccine.2018.09.044
Bartelt, L. A., Bolick, D. T., Kolling, G. L., Roche, J. K., Zaenker, I. E., Lara, A. M., Noronha, F. J., Cowardin, C. A., Moore, J. H., Turner, J. R., Warren, C. A., Buck, G. A., & Guerrant, R. L., (2016). Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model. PLoS Neglected Tropical Diseases, 10, n. 7, 1–29. doi: 10.1371/journal.pntd.0004820
Cui, Z., Dong, H., Wang, R., Jian, F., Zhang, S., Ning, C., & Zhang, L. (2018). A canine model of experimental infection with Cryptosporidium canis Zhaohui. Experimental Parasitology, 195, 19–23. doi: 10.1016/j.exppara.2018.09.019
Elguero, M. E., Tomazic, M. L., Montes, M. G., Florin-christensen, M., Schnittger, L., & Nusblat, A. D. (2019). Veterinary Parasitology The Cryptosporidium parvum gp60 glycoprotein expressed in the ciliate Tetrahymena thermophila is immunoreactive with sera of calves infected with Cryptosporidium oocysts. Veterinary Parasitology, 271, 45–50. doi: 10.1016/j.vetpar.2019.06.008
Hemphill, A., Müller, N., & Müller, J. (2019). Comparative Pathobiology of the Intestinal Protozoan Parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum. Pathogens, 8, 116. doi: 10.3390/pathogens8030116
Huang, Y., Cao, W., Shi, K., Mi, R., Lu, K., Han, X., & Chen, Z. (2017). Protective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice. Parasite Immunology, 39, n. 9, 0–2. doi: 10.1111/pim.12449
Joachim, A., Altreuther, G., Bangoura, B., Charles, S., Daugschies, A., Hinney, B., Lindsay, D. S., Mundt, H.C., Ocak, M., & Sotiraki, S. (2018). W A A V P Guideline for Evaluating the Efficacy of Anticoccidials in Mammals (Pigs, Dogs, Cattle, Sheep). Veterinary Parasitology, 15, 102–119. doi: 10.1016/j.vetpar.2018.02.029
Kitchenham, B., Brereton, O. P., Budgen, D., Turner, M., Bailey, J., & Linkman, S. (2009). Systematic literature reviews in software engineering – A systematic literature review. Information and Software Technology, 51, n. 1, 7–15. doi:10.1016/j.infsof.2008.09.009
Kwakye-Nuako, G., Boampong, J. N., Dong, M. K., Obiri-Yeboah, D., Opoku, Y. K., Amoako-Sakyi, D., & Asare, K. K. (2016). Modulation of cyptosporidiosis by CD4 levels in chronic diarrhoea HIV/AIDS individuals visiting Tarkwa Municipal hospital, Ghana. Asian Pacific Journal of Tropical Disease, 6, n. 10, 770–775. doi: 10.1016/S2222-1808(16)61127-1
Lippuner, C., Ramakrishnan, C., Basso, W. U., Schmid, M. W., Okoniewski, M., Smith, N. C., Hässig, M., Deplazes, P., & Hehl, A. B. (2018). RNA-Seq analysis during the life cycle of Cryptosporidium parvum reveals significant differential gene expression between proliferating stages in the intestine and infectious sporozoites. International Journal for Parasitology, 48, 413–422. doi: 10.1016/j.ijpara.2017.10.007
Mammeri, M., Chevillot, A., Thomas, M., Polack, B., Julien, C., Marden, J.-P., Auclair, E., Vallée, I., & Tarik, K. A. (2018). Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice. Experimental Parasitology, 194, 1–8. doi: 10.1016/j.exppara.2018.09.003
Mcnair, N. N., Bedi, C., Shayakhmetov, D. M., Arrowood, M. J., & Jan, R. M. (2018). Inflammasome components caspase-1 and adaptor protein apoptosis-associated speck-like proteins are important in resistance to Cryptosporidium parvum. Microbes and Infection, 20, 369–375. doi: 10.1016/j.micinf.2018.04.006
Robinson, G., Elwin, K., & Chalmers, R. M. (2019). Cryptosporidium Diagnostic Assays: Molecular Detection. Cryptosporidium. 11–22. doi: 10.1007/978-1-4939-9748-0_2
Ryan, U., Zahedi, A., & Paparini, A. (2016). Cryptosporidium in humans and animals - a one health approach to prophylaxis. Parasite. Immunol. doi: 10.1111/pim.12350
Sateriale, A., Slapeta, J., Baptista, R., Engiles, J. B., Gullicksrud, J. A., Hebert, G. T., Brooks, C. F., Kugler, E. M., Kissinger, J. C., Hunter, C. A., & Striepen, B. A. (2019). Genetically Tractable, Natural Mouse Model of Cryptosporidiosis Offers Insights into HostProtective Immunity. Cell Host & Microbe, 26, 135–146. doi: 10.1016/j.chom.2019.05.006
Tomazic, M. L., Rodriguez, A. E., Lombardelli, J., Poklepovich, T., Garro, C., Galarza, R., Tiranti, K., & Schnittger, L. (2018). Identification of novel vaccine candidates against cryptosporidiosis of neonatal bovines by reverse vaccinology. Veterinary Parasitology, 264, 74–78. doi: 10.1016/j.vetpar.2018.11.007
Tosini, F., Ludovisi, A., Tonanzi, D., Amati, M., Cherchi, S., & Pozio, E. (2019). Delivery of SA35 and SA40 peptides in mice enhances humoral and cellular immune responses and confers protection against Cryptosporidium parvum infection. Parasites & Vectors, 15, 1–15. doi: 10.1186/s13071-019-3486-8
Yang, Y., Xue, X., Yang, Y., Chen, X., & Du, A. (2016). Efficacy of a potential DNA vaccine encoding Cryptosporidium baileyi rhomboid protein against homologous challenge in chickens. Veterinary Parasitology, 230, 5–11. doi: 10.1016/j.vetpar.2016.05.024
Zahedi, A., Gofton, A. W., Greay, T., Monis, P., Oskam, C., Ball, A., Bath, A., Watkinson, A., Robertson, I., & Ryan, U. (2018). Profiling the diversity of Cryptosporidium species and genotypes in wastewater treatment plants in Australia using next generation sequencing. Science of the Total Environment, 644, 635–648. doi: 10.1016/j.scitotenv.2018.07.024
How to Cite
Copyright (c) 2021 Débora Regina Romualdo da Silva; Talita Carolina Bragança de Oliveira; Bárbara Braga Ferreira Marta; Carolina Beatriz Baptista; Maria Cecília Zonetti Bottaro; Katia Denise Saraiva Bresciani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.